A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris
Status:
Recruiting
Trial end date:
2022-11-30
Target enrollment:
Participant gender:
Summary
Acne vulgaris is a common disease of both males and females, usually manifesting initially
during adolescence. The use of retinoic acid analogues such as adapalene, tazarotene and
isotretinoin are also commonly prescribed to treat inflammation; dysregulated sebum
production and comedonal acne. This study seeks to evaluate the efficacy and safety of
concomitant use of both AMZEEQ® and oral isotretinoin compared to oral isotretinoin only use
and to explore sequence dosing of both products as part of a long-term management protocol
for acne vulgaris.